XBP1 activation is involved in processes that lead to its mRNA splicing unconventionally when potentiated by the endonuclease inositol-requiring enzyme 1 (IRE1), expressing the potential to serve as an mRNA marker for pathogenic astrocytes in MS. This evidence concerns the gene XBP1 and myeloid sarcoma.